Updated Jul 16, 2026
FITZGERALD EDWARD M has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Edward M. Fitzgerald is linked to Parabilis Medicines, Inc. in the context of SEC filings dating through June 11, 2026. The provided context confirms an association with Parabilis Medicines, but does not specify his exact title or duties in the company. Therefore, while he appears as an insider or executive figure in the 2026 SEC filings, the precise role (e.g., director, officer, or other) cannot be confirmed from the given excerpt. Additional SEC documents or the company’s investor relations materials would be needed to pin down his official position and responsibilities.
| Role | Insider |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-15 | PBLS | Parabilis Medicines, Inc. | J — Other acquisition / disposition | 5.3K | — | |
| 2026-06-15 | PBLS | Parabilis Medicines, Inc. | J — Other acquisition / disposition | 3.9K | — | |
| 2026-06-15 | PBLS | Parabilis Medicines, Inc. | J — Other acquisition / disposition | 5.5K | — |
Edward M. Fitzgerald is linked to Parabilis Medicines, Inc. in the context of SEC filings dating through June 11, 2026. The provided context confirms an association with Parabilis Medicines, but does not specify his exact title or duties in the company. Therefore, while he appears as an insider or executive figure in the 2026 SEC filings, the precise role (e.g., director, offic…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live FITZGERALD EDWARD M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.